معرفی
Carol Pollock is a Professor at the University of Sydney's Northern Clinical School, affiliated with the Kolling Institute of Medical Research. Her research focuses on diabetic kidney disease, chronic kidney disease (CKD) management, and maternal-fetal programming of renal health.
- Thematic areas: Obesity, Diabetes, Cardiovascular Disease, Healthy Ageing, and Lifespan
- Methodological approaches: Animal models, Cellular/molecular studies, and Translational research
- Clinical specialty: Nephrology
Her work explores epigenetic mechanisms in maternal obesity-related kidney disease, SGLT2 inhibitors for cardiorenal protection, and novel biomarkers like urinary exosomes and volatile organic compounds. Recent studies emphasize intergenerational metabolic programming and renoprotective drug development.
Key publication trends (2023-2025) include:
- Diabetic nephropathy (2025: SGLT2 inhibitors, YAP1 pathways)
- CKD progression (2024: DISCOVER cohort, hyperkalemia management)
- Maternal environmental impacts (2025: PM2.5 exposure, fetal kidney health)
- Renal fibrosis (2023: i-body AD-214, CXCR4 blockade)
- Translational nephrology (2024: urinary cell imaging, exosome therapy)
- Global CKD guidelines (2024: Asia-specific management frameworks)
Her team mentors PhD students Daisy Chen, Wenyang Shi, and Chi Tran, investigating stem cell therapies and renal regeneration in diabetic and acute kidney injury models.
